GFR decline as an end point in trials of CKD: a viewpoint from the FDA.
作者信息
Thompson Aliza, Lawrence John, Stockbridge Norman
机构信息
Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.
出版信息
Am J Kidney Dis. 2014 Dec;64(6):836-7. doi: 10.1053/j.ajkd.2014.09.006. Epub 2014 Oct 31.
PMID:25446026
Abstract
摘要
Zotero 插件